Dipropizine or dropropizine
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162621This classification denotes an antispasmotic agent with the molecular formula C13H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U0K8WHL37U, chemically known as 1,2-propanediol, 3-(4-phenyl-1-piperazinyl)-, (r,s)- but more generally known as dropropizine, which bears US NIH Compound Identifier 3169. European Medicines Agency schedules Dropropizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06412MIG. The term DROPROPIZINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules dropropizine in its Anatomical Therapeutic Chemical (ATC) Classification. DROPROPIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Dipropizine or dropropizine bears US NLM identifiers UMLS ID C0058425 and NCI Concept Code C73179. SMILES: OC(CN1CCN(CC1)C1CCCCC1)CO.
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.